The ability of a single cell to move from the primary tumor to metastatic site is facilitated through the transition from an epithelial phenotype (CD44+/CD24+) to a mesenchymal phenotype (CD44+/CD24-) [21,23]. This evidence concerns the gene CD44 and neoplasm.